Immunohematology Metrics

TOP ARTICLES

PAGEVIEWS UNIQUE PAGEVIEWS BOUNCE RATE AVG. TIME SPENT EXIT RATE AVG. GENERATION TIME
Recognizing and resolving ABO discrepancies 1019 492 58% 18 93% 3.323s
Separation of multiple antibodies by adsorption with allogeneic red blood cells 445 201 58% 41 85% 3.36s
Neonatal testing leading to the identification of Bh (para-Bombay) phenotype in the mother: case report with review of the literature 195 143 54% 71 67% 2.363s
Investigation of anemia of unknown origin 196 131 49% 73 63% 4.254s
The Cromer blood group system: an update 136 119 69% 59 72% 1.409s
Acute hemolytic transfusion reaction caused by anti-Yta 152 111 69% 82 82% 2.152s
An interesting case of alloanti-M exhibiting typical dosage phenomenon 127 98 49% 80 59% 2.343s
Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization 305 97 48% 38 67% 1.788s
Concordance of two polymerase chain reaction–based blood group genotyping platforms for patients with sickle cell disease 555 85 35% 38 60% 1.841s
Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype 318 78 43% 36 68% 2.84s
Effect of cryopreservation on a rare McLeod donor red blood cell concentrate 95 78 63% 140 63% 2.28s
The Vel blood group system: a review 193 75 60% 26 87% 2.762s
Dithiothreitol treatment of red blood cells 179 74 63% 13 88% 1.743s
Statistical model for prediction of ABO hemolytic disease of the fetus and newborn in India 92 71 56% 56 72% 2.63s
Freezing and recovering rare red blood cells using glycerol 164 70 76% 39 69% 2.577s
Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele 87 68 59% 83 54% 2.428s
Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab 138 63 53% 33 90% 4.101s
Hemovigilance and the Notify Library 81 61 95% 4 85% 1.996s
A detailed flow cytometric method for detection of low-level in vivo red blood  cell–bound IgG, IgA, and IgM 126 61 53% 22 90% 3.304s

PLUMX

METRICS

PLATFORM